In DKD, emerging evidence shows altered m6A marks in patients: diabetic nephropathy patients exhibit reduced global m6A levels in urine and blood, alongside decreased FTO expression (Li & Mu, 2024). The gene discussed is FTO; the disease is diabetic kidney disease.